Genentech, of Roche (RHHBY), and Biogen (BIIB) Get U.S. FDA Approval for Rituxan
Tweet Send to a Friend
Genentech, Inc., a wholly owned member of the Roche Group (OTC: RHHBY), and Biogen Idec (NASDAQ: BIIB) announced today the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
